Nuvo Pharmaceuticals reports that it has extended the negotiation period with Aralez Pharmaceuticals and Deerfield Management for its planned acquisition of a portfolio of more than 20 revenue-generating Aralez assets.
The company says it will not provide any further updates on the proposed transaction.
Date: August 27, 2018
Source: Seeking Alpha
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.